Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

JDOC vs SWHFX overlap: 57% of top holdings shared

Bottom line

How much do JDOC and SWHFX overlap?

57% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 52.8% of JDOC's assets and 53.1% of SWHFX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

JDOCSWHFX
Weight overlap (top 25)57%
Shared holdings13
Weight in shared holdings52.8%53.1%
Total positions6180
Expense ratio0.65%0.8%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings JDOC and SWHFX have in common

Holding% of JDOC% of SWHFXOverlap
AbbVie, Inc.7.85%5.81%5.81%
Eli Lilly & Co.7.76%13.92%7.76%
UnitedHealth Group, Inc.5.85%4.74%4.74%
Merck & Co., Inc.4.82%4.98%4.82%
Johnson & Johnson4.82%6.94%4.82%
Thermo Fisher Scientific, Inc.3.73%2.16%2.16%
Bristol-Myers Squibb Co.3.57%2.44%2.44%
Abbott Laboratories3.11%1.60%1.60%
Roche Holding AG2.82%2.29%2.29%
GSK plc2.47%1.73%1.73%
Stryker Corp.2.23%2.11%2.11%
Danaher Corp.2.16%1.47%1.47%
Novartis AG1.60%2.92%1.60%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in JDOC

  1. AstraZeneca plc — 3.76%
  2. CVS Health Corp. — 2.83%
  3. Novo Nordisk A/S — 2.61%
  4. Cencora, Inc. — 2.07%
  5. Argenx SE — 2.06%
  6. Intuitive Surgical, Inc. — 1.93%
  7. Edwards Lifesciences Corp. — 1.73%
  8. IQVIA Holdings, Inc. — 1.71%
  9. Teva Pharmaceutical Industries Ltd. — 1.60%
  10. Regeneron Pharmaceuticals, Inc. — 1.60%
  11. Biogen, Inc. — 1.56%
  12. Cardinal Health, Inc. — 1.51%

Only in SWHFX

  1. Gilead Sciences Inc — 3.24%
  2. Amgen Inc — 2.58%
  3. Medtronic PLC — 2.29%
  4. Vertex Pharmaceuticals Inc — 1.89%
  5. Boston Scientific Corp — 1.60%
  6. Cigna Group/The — 1.51%
  7. Elevance Health Inc — 1.45%
  8. Incyte Corp — 1.37%
  9. Ipsen SA — 1.34%
  10. Sanofi SA — 1.31%
  11. Becton Dickinson & Co — 1.24%
  12. Astellas Pharma Inc — 1.19%

Asset mix

Asset typeJDOCSWHFX
Stocks99.2%99.0%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryJDOCSWHFX
US75.2%78.6%
GB6.2%3.4%
CH4.4%5.2%
IE0.4%4.5%
DK4.0%0.7%
FR—2.6%
JP2.5%2.3%
NL2.4%0.7%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do JDOC and SWHFX overlap?
About 57% by weight. 13 securities appear in both funds' top 25 holdings; they make up 52.8% of JDOC's assets and 53.1% of SWHFX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do JDOC and SWHFX have in common?
The largest shared holdings are Eli Lilly & Co., AbbVie, Inc., Merck & Co., Inc., Johnson & Johnson, UnitedHealth Group, Inc..
Should I own both JDOC and SWHFX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, JDOC or SWHFX?
SWHFX is broader, with 80 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.